For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Applications
A preliminary chromatographic run on Valsartan and Sacubitril after degradation Quality-By-Design Approach to Stability Indicating Method Development
27663
Separation Mode: Reversed Phase
Reversed Phase
F5
HPLC
Antihypertensive Agents
Pharmaceutical
Pharmaceutical
Therapeutic / Clinical

A preliminary chromatographic run on Valsartan and Sacubitril after degradation Quality-By-Design Approach to Stability Indicating Method Development

Analytes
1
2
3
4
5
6
7
8
9
10Valsartan
11Sacubutril
12
13
14
15
Details
LC Conditions (App ID: 27663)
Column:
Brand Name:
Kinetex
Part No:
Phase Name:
F5
System:
Waters HPLC System Waters HPLC System
Similar Applications
search
No Data